Simposio Avances en Infertilidad

Adolfo F. Rechkemmer

doi:10.31403/rpgo.v60i103

Authors

Adolfo F. Rechkemmer Presidente de la Sociedad Peruana de Fertilidad Ex Presidente Sociedad Peruana de Obstetricia y Ginecología

DOI:

https://doi.org/10.31403/rpgo.v60i103

Abstract

En 1978, Robert Edwards y Patrick Steptoe lograron el primer embarazo con fertilización in vitro en una mujer con obstrucción tubárica bilateral; este hecho marcó un hito en el tratamiento de la infertilidad y desde entonces las técnicas de reproducción asistida no han dejado de perfeccionarse. En 1987, se logró obtener óvulos por punción ovárica guiada por ecografía transvaginal. En 1992, Palermo logró el primer embarazo con la técnica de inyección de espermatozoide intracitoplasmática (ICSI). A mediados de la década de los 90 se introdujo la biología molecular a la medicina reproductiva, lográndose el desarrollo de nuevos tratamientos de gran trascendencia para las parejas con problemas de infertilidad.

Downloads

Download data is not yet available.

References

Wainer R, Albert M, Dorion A, Bailly M, Bergere M, Lombroso R, Gombault M, Selva J. Influence of the number of motile spermatozoa inseminated and of their morphology on the success of intrauterine insemination. Hum Reprod. 2004;19 (9):2060-5.

O’Flynn O’Brien KL, Varghese AC, Agarwal A. The genetic causes of male factor infertility: a review. Fertil Steril. 2010;93(1):1-12.

Guzick DS, Overstreet JW, Factor-Litvak P, Brazil CK, Nakajima ST, Coutifaris C, et al. Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med. 2001;345(19):1388-93.

Bungum M, Humaidan P, Axmon A, Spano M, Bungum L, Erenpreiss J, et al. Sperm DNA integrity assessment in prediction of assisted reproduction technology outcome. Hum Reprod. 2007;22(1):174-9.

Robinson L, Gallos ID, Conner SJ, Rajkhowa M, Miller D, Lewis S, et al. The effect of sperm DNA fragmentation on miscarriage rates: a systematic review and meta-analysis. Hum Reprod. 2012;27(10):2908-17.

Boe-Hansen GB, Fedder J, Ersboll AK, Christensen P. The sperm chromatin structure assay as a diagnostic tool in the human fertility clinic. Hum Reprod 2006;21(6):1576-82.

Babayof R, Margaliot EJ, Huleihel M, Amash A, Zylber-Haran E, Gal M, Brooks B, Mimoni T, Eldar-Geva T. Serum inhibin A, VEGF and TNF alpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial. Hum Reprod. 2006;21:1260-5.

Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation síndrome: a prospective randomized controlled study. Fertil Steril. 2008;89:84-91.

Humaidan P, Ejdrup Bredkjaer H, Bungum L, Bungum M, Grondahl ML, Westergaard L, Yding Andersen C. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod. 2005;20:1213-20.

Kolibianakis EM, Schultze-Mosgau A, Schroer A, van Steirteghem A, Devroey P, Diedrich K, Griesinger G. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod. 2005;10:2887-92.

Munné S, Chen S, Colls P, Garrisi J, Zheng X, Cekleniak N, et al. Maternal age, morphology, development and chromosome abnormalities in over 6000 cleavage-stage embryos. Reprod Biomed Online. 2007;14:628-34.

Abdelhadi I, Colls P, Sandalinas M, Escudero T, Munné S. Preimplantation genetic diagnosis of numerical abnormalities for 13 chromosomes. Reprod Biomed Online. 2003;6:226-31.